Dr. Judit Anna Farkas, MD

Dr. Farkas practices at Physician Groups LC in Saint Louis, Missouri.

Dr. Farkas' NPI, 1912327339, was assigned on April 24, 2014. Dr. Farkas holds Missouri license 2017022855.

Dr. Farkas' primary practice is Physician Groups LC, at 670 Mason Ridge Center Dr, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (314) 996-7644.

Dr. Farkas' primary practice is Physician Groups LC in Saint Louis, Missouri. Dr. Farkas is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SSM Health Medical Group. Dmand AI also links Dr. Farkas to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farkas practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Farkas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Farkas is licensed in Missouri.

CMS data shows 260 Medicare services from Dr. Farkas across 2 procedure codes in 2024, for 157 Medicare patients. Medicare paid $17,700 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Farkas in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farkas' median patient age at 62, with 69% women.

In 2024, Dr. Farkas wrote 7,041 Medicare Part D claims for 664 patients. 86% of them were for generic drugs. CMS names the drug for 6,284 of them, across 109 drugs with 11 or more claims each, at $575,518 in total drug cost. In 2023, CMS named 6,331 claims across 115 drugs.

Dr. Farkas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Farkas from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $15.